» Articles » PMID: 22013489

Hispolon Protects Against Acute Liver Damage in the Rat by Inhibiting Lipid Peroxidation, Proinflammatory Cytokine, and Oxidative Stress and Downregulating the Expressions of INOS, COX-2, and MMP-9

Overview
Date 2011 Oct 21
PMID 22013489
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The hepatoprotective potential of hispolon against carbon tetrachloride (CCl(4))-induced liver damage was evaluated in preventive models in rats. Male rats were intraperitoneally treated with hispolon or silymarin once daily for 7 consecutive days. One hour after the final hispolon or silymarin treatment, the rats were injected with CCl(4). Administration with hispolon or silymarin significantly decreased the alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in serum and increased the activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), and glutathione (GSH) content and decreased the malondialdehyde (MDA) content in liver compared with CCl(4)-treated group. Liver histopathology also showed that hispolon reduced the incidence of liver lesions induced by CCl(4). In addition, hispolon decreased nitric oxide (NO) production and tumor necrosis factor (TNF-α), inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) activation in CCl(4)-treated rats. We also examined the involvement of matrix metalloproteinase (MMP)-9 in the development of CCl(4)-induced liver damage in rats. Hispolon inhibited the expression of MMP-9 protein, indicating that MMP-9 played an important role in the development of CCl(4)-induced rat liver damage. Therefore, we speculate that hispolon protects rats from liver damage through their prophylactic redox balancing ability and anti-inflammation capacity.

Citing Articles

Antioxidant, anti-acetylcholinesterase, and anti-amyloid-β peptide aggregations of hispolon and its analogs in vitro and improved learning and memory functions in scopolamine-induced ICR mice.

Yang C, Li C, Sie Y, Chen L, Yuan Y, Hou W Bot Stud. 2024; 65(1):38.

PMID: 39692936 PMC: 11655744. DOI: 10.1186/s40529-024-00443-x.


The clinical anti-inflammatory effects and underlying mechanisms of silymarin.

Zhao Y, Zhou Y, Gong T, Liu Z, Yang W, Xiong Y iScience. 2024; 27(11):111109.

PMID: 39507256 PMC: 11539592. DOI: 10.1016/j.isci.2024.111109.


Research Progress of Bioactive Components in spp.

Lu J, Su M, Zhou X, Li D, Niu X, Wang Y Molecules. 2024; 29(6).

PMID: 38542832 PMC: 10976032. DOI: 10.3390/molecules29061195.


Neuroprotective effects of gemfibrozil in neurological disorders: Focus on inflammation and molecular mechanisms.

Sadeghi Ivraghi M, Zamanian M, Gupta R, Achmad H, Alsaab H, Hjazi A CNS Neurosci Ther. 2023; 30(3):e14473.

PMID: 37904726 PMC: 10916451. DOI: 10.1111/cns.14473.


Diarylheptanoids/sorafenib as a potential anticancer combination against hepatocellular carcinoma: the p53/MMP9 axis of action.

Elmetwalli A, Diab T, Albalawi A, El-Naggar S, El-Far A, Ghedan A Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(10):2501-2517.

PMID: 37145126 PMC: 10497687. DOI: 10.1007/s00210-023-02470-0.


References
1.
Chang H, Sheu M, Yang C, Lu T, Chang Y, Peng W . Analgesic effects and the mechanisms of anti-inflammation of hispolon in mice. Evid Based Complement Alternat Med. 2009; 2011:478246. PMC: 3136186. DOI: 10.1093/ecam/nep027. View

2.
Ko J, Lee S, Lim K . Rhus verniciflua Stokes glycoprotein (36kDa) has protective activity on carbon tetrachloride-induced liver injury in mice. Environ Toxicol Pharmacol. 2011; 22(1):8-14. DOI: 10.1016/j.etap.2005.10.005. View

3.
Bruccoleri A, Gallucci R, Germolec D, Blackshear P, Simeonova P, Thurman R . Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology. 1997; 25(1):133-41. DOI: 10.1002/hep.510250125. View

4.
Kadiiska M, Gladen B, Baird D, Dikalova A, Sohal R, Hatch G . Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl(4) poisoning?. Free Radic Biol Med. 2000; 28(6):838-45. DOI: 10.1016/s0891-5849(00)00198-2. View

5.
Farombi E . Mechanisms for the hepatoprotective action of kolaviron: studies on hepatic enzymes, microsomal lipids and lipid peroxidation in carbontetrachloride-treated rats. Pharmacol Res. 2000; 42(1):75-80. DOI: 10.1006/phrs.1999.0648. View